Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

First launch for Aggrastat, a new antiplatelet agent for acute coronary syndrome

May 26, 1998

No Comments

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

No Comments

BLA and MAA filed for recombinant factor VIII product for hemophilia A

May 22, 1998

No Comments

Fibrinogen receptor antagonists claimed by DuPont Merck

May 22, 1998

No Comments

U.S. market introduction announced for Plavix

May 22, 1998

No Comments

DuPont Merck presents new anticoagulants

May 21, 1998

No Comments

Selective thrombin inhibitors described by Merck scientists

May 20, 1998

No Comments

Cor's fibrinogen antagonist on the way to market

May 19, 1998

No Comments

Recombinant antithrombin III pivotal clinical trials begin

May 18, 1998

No Comments

Merck characterizes new orally bioavailable thrombin inhibitor: L-374087

May 18, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

First launch for Aggrastat, a new antiplatelet agent for acute coronary syndrome

FDA approves Aggrastat, the first platelet blocker for unstable angina

BLA and MAA filed for recombinant factor VIII product for hemophilia A

Fibrinogen receptor antagonists claimed by DuPont Merck

U.S. market introduction announced for Plavix

DuPont Merck presents new anticoagulants

Selective thrombin inhibitors described by Merck scientists

Cor's fibrinogen antagonist on the way to market

Recombinant antithrombin III pivotal clinical trials begin

Merck characterizes new orally bioavailable thrombin inhibitor: L-374087

Today's news in brief

Today's news in brief

Boryung invests $10M in Intuitive Machines for outer space R&D

Phase II Huntington’s tie-up with Novartis could edge $3B for PTC

Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal

Hematologic RSS

Hematologic
RSS